CoChat
Sign Up
Cited by 3Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and MyoclonusMetabolism and Genetic Disorders

The DOI matches its Crossref record.

Re-engineering iduronate 2-sulfatase for penetration of the blood-brain barrier via transport on the insulin receptor

Boado, Ruben J., Hui, Eric K.-W., Lu, Jeff Z., Pardridge, William M.·2014·Molecular Genetics and Metabolism
DOI 10.1016/j.ymgme.2013.12.043
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ymgme.2013.12.043

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AGT-182 (iduronate 2 sulfatase fused with monoclonal antibody against insulin receptor) is in phase 1 trial for mycopolysaccharoidosis II disease.

    “and iduronate 2 sulfatase fused with monoclonal antibody against insulin receptor (AGT-182) that is in phase 1 trial for mycopolysaccharoidosis II disease (69).”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [69]

Citations

Cited by

Sorted by citations

Metadata

Authors
Boado, R. J., Hui, E. K.-W., Lu, J. Z., & Pardridge, W. M.
Affiliations
ArmaGen (United States) (US)
ORCID
Venue
Molecular Genetics and Metabolism
Publisher
Elsevier BV
Published
2014-02
Volume
111
Issue
2
Pages
S27
ISSN
1096-7192 (ISSN-L)
DOI
10.1016/j.ymgme.2013.12.043
OpenAlex
W2018832689
Cited by
3
References
0
Citations by year
2018: 1 · 2017: 1 · 2016: 1
FWCI
0.44
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
Molecular Genetics and Metabolism (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
Hunter syndrome, iduronate-2-sulfatase, enzyme replacement therapy, idursulfase, hematopoietic stem cell transplantation, cord blood transplantation, blood-brain barrier penetration, lysosomal storage disease, cognitive impairment, disease progression, familial case

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review